Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis

Affiliations

• ¹ Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
• ² AmMax Bio, Inc., Redwood City, CA, USA.
• ³ National Heart and Lung Institute, Imperial College London, London, UK.
• ⁴ Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK.
• ⁵ Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.